WallStreetZenWallStreetZen

NYSE: JNJ
Johnson & Johnson Earnings & Revenue

Open Broker Account
OverviewForecastEarnings
DividendOwnership

JNJ past earnings growth

How has JNJ's earnings growth performed historically?
Company
3.56%
Industry
53.02%
Market
53.18%
JNJ's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
JNJ's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
JNJ's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

JNJ past revenue growth

How has JNJ's revenue growth performed historically?
Company
7.17%
Industry
19.06%
Market
113.02%
JNJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
JNJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
JNJ's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

JNJ earnings and revenue history

Current Revenue
$95.6B
Current Earnings
$18.4B
Current Profit Margin
19.2%
JNJ's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

JNJ Return on Equity

Current Company
24.9%
Current Industry
41.5%
Current Market
25.7%
JNJ's Return on Equity (24.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when JNJ announces earnings.

JNJ Return on Assets

Current Company
10.2%
Current Industry
10.3%
JNJ is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

JNJ Return on Capital Employed

Current Company
15.44%
Current Industry
15.9%
JNJ's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

JNJ vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
JNJ$95.59B$27.69B$18.37B+5.68%+3.07%
LLY$29.07B$7.84B$5.69B+5.73%+21.97%
ABBV$57.35B$24.50B$12.64B+16.51%+11.58%
PFE$101.13B$37.05B$29.31B+14.08%+30.48%
MRK$57.17B$22.10B$16.58B+7.40%+28.81%
View Top General Drug Manufacturer Stocks

JNJ earnings dates

Next earnings date
Oct 18, 2022

Johnson & Johnson Earnings & Revenue FAQ

What were JNJ's earnings last quarter?

On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q2 2022 earnings per share (EPS) of $1.83, up 23.43% year over year. Total Johnson & Johnson earnings for the quarter were $4.81 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was $2.39.

If you're new to stock investing, here's how to buy Johnson & Johnson stock.

What was JNJ's earnings growth in the past year?

As of Q4 2022, Johnson & Johnson's earnings has grown 3.56% year over year. This is 49.46 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 53.02%. Johnson & Johnson's earnings in the past year totalled $18.37 billion.

What is JNJ's earnings date?

Johnson & Johnson's earnings date is Invalid Date. Add JNJ to your watchlist to be reminded of JNJ's next earnings announcement.

What was JNJ's revenue last quarter?

On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q2 2022 revenue of $24.02 billion up 3.04% year over year. In the same quarter last year, Johnson & Johnson's revenue was $23.31 billion.

What was JNJ's revenue growth in the past year?

As of Q4 2022, Johnson & Johnson's revenue has grown 7.17% year over year. This is 11.89 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 19.06%. Johnson & Johnson's revenue in the past year totalled $95.59 billion.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.